Northway Biotech Capacity Update April 2025: Large Molecule Development
Source: Northway Biotech
Detra Glinatsis, Vice President of Business Development, presents the advanced capabilities, strategic growth, and expanding capacity of Northway Biotech, a global biologics CDMO. With over two decades of experience and a robust track record of more than 180 successfully executed projects, the organization operates three facilities — one in Waltham, Massachusetts, and two in Vilnius, Lithuania — positioned to serve both US and European markets.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
Northway Biotech
This website uses cookies to ensure you get the best experience on our website. Learn more